Acute and chronic heroin dependence in mice: Contribution of opioid and excitatory amino acid receptors

European Journal of Pharmacology

Volumn 586, Issue 1-3, 2008, Pages 179-188

  Klein, Gad ^a   Juni, Aaron ^a   Arout, Caroline A ^c   Waxman, Amanda R ^a   Inturrisi, Charles E ^b   Kest, Benjamin ^a,c  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

Excitatory amino acid receptor; Heroin; Naloxone precipitated withdrawal; Opioid receptor

Indexed keywords

7 BENZYLIDENENALTREXONE; AMPA RECEPTOR; DECAHYDRO 6 [2 (1H TETRAZOL 5 YL)ETHYL] 3 ISOQUINOLINECARBOXYLIC ACID; DELTA OPIATE RECEPTOR; DIZOCILPINE; EXCITATORY AMINO ACID RECEPTOR; KAPPA OPIATE RECEPTOR; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NALOXONE; NALTRIBEN; NORBINALTORPHIMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; HEROIN DEPENDENCE; JUMPING; MALE; MORPHINE ADDICTION; MOUSE; NONHUMAN; PHYSIOLOGY; PRIORITY JOURNAL;

ACUTE DISEASE; ANIMALS; BEHAVIOR, ANIMAL; BENZYLIDENE COMPOUNDS; CHRONIC DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; HEROIN DEPENDENCE; MALE; MICE; NALOXONE; NALTREXONE; NARCOTIC ANTAGONISTS; RECEPTORS, AMPA; RECEPTORS, GLUTAMATE; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, OPIOID; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA; SUBSTANCE WITHDRAWAL SYNDROME; TIME FACTORS;

EID: 43549118596     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.02.035     Document Type: Article

References (50)

1. Beart P.M., and Lodge D. Chronic administration of MK-801 and the NMDA receptor: further evidence for reduced sensitivity of the primary acceptor site from studies with the cortical wedge preparation. J. Pharm. Pharmacol. 42 (1990) 354-355
2. Berrendero F., Kieffer B.L., and Maldonado R. Attenuation of nicotine-induced antinociception, rewarding effects, and dependence in mu-opioid receptor knock-out mice. J. Neurosci. 22 (2002) 10935-10940
3. Bettler B., and Mulle C. Review: neurotransmitter receptors. II. AMPA and kainate receptors. Neuropharmacology 34 (1995) 123-139
4. Bliss T.V., and Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361 (1992) 31-39
5. Breivik H. Opioids in cancer and chronic non-cancer pain therapy - indications and controversies. Acta Anaesthesiol. Scand. 45 (2001) 1059-1066
6. Cui C.L., Wu L.Z., and Han J.S. Spinal kappa-opioid system plays an important role in suppressing morphine withdrawal syndrome in the rat. Neurosci. Lett. 295 (2000) 45-48
7. Daniels D.J., Lenard N.R., Etienne C.L., Law P.Y., Roerig S.C., and Portoghese P.S. Opioid-induced tolerance and dependence in mice is modulated by the distance between pharmacophores in a bivalent ligand series. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 19208-19213
8. Endoh T., Matsuura H., Tanaka C., and Nagase H. Nor-binaltorphimine: a potent and selective kappa-opioid receptor antagonist with long-lasting activity in vivo. Arch. Int. Pharmacodyn. Ther. 316 (1992) 30-42
9. El-Kadi A.O., and Sharif S.I. The influence of various experimental conditions on the expression of naloxone-induced withdrawal symptoms in mice. Gen. Pharmacol. 25 (1994) 1505-1510
10. George S.R., Fan T., Xie Z., Tse R., Tam V., Varghese G., and O'Dowd B.F. Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties. J. Biol. Chem. 275 (2000) 26128-26135
11. Ikeda K., Ichikawa T., Kobayashi T., Kumanishi T., Oike S., and Yano R. Unique behavioural phenotypes of recombinant-inbred CXBK mice: partial deficiency of sensitivity to mu- and kappa-agonists. Neurosci. Res. 34 (1999) 149-155
12. Inoue M., Mishina M., and Ueda H. Locus-specific rescue of GluRepsilon1 NMDA receptors in mutant mice identifies the brain regions important for morphine tolerance and dependence. J. Neurosci. 23 (2003) 6529-6536
13. Inturrisi C.E., Schultz M., Shin S., Umans J.G., Angel L., and Simon E.J. Evidence from opiate binding studies that heroin acts through its metabolites. Life Sci. 33 (1983) 773-776
14. Jasinski D.R. Assessment of the abuse potentiality of morphine like drugs (methods used in man). In: Martin W.R. (Ed). Handbook of Experimental Pharmacology (1977), Springer-Verlag, Berlin 197-258
15. Kest B., Lee C.E., McLemore G.L., and Inturrisi C.E. An antisense oligodeoxynucleotide to the delta opioid receptor (DOR-1) inhibits morphine tolerance and acute dependence in mice. Brain Res. Bull. 39 (1996) 185-188
16. Kest B., Palmese C.A., Hopkins E., Adler M., and Juni A. Assessment of acute and chronic morphine dependence in male and female mice. Pharmacol. Biochem. Behav. 70 (2001) 149-156
17. Kest B., Palmese C.A., Hopkins E., Adler M., Juni A., and Mogil J.S. Naloxone-precipitated withdrawal jumping in 11 inbred mouse strains: evidence for common genetic mechanisms in acute and chronic morphine physical dependence. Neuroscience 115 (2002) 463-469
18. Knapp R.J., Malatynska E., Collins N., Fang L., Wang J.Y., Hruby V.J., Roeske W.R., and Yamamura H.I. Molecular biology and pharmacology of cloned opioid receptors. FASEB J. 9 (1995) 516-525
19. Koyuncuoglu H., Nurten A., Yamanturk P., and Nurten R. The importance of the number of NMDA receptors in the development of supersensitivity or tolerance to and dependence on morphine. Pharmacol. Res. 39 (1999) 311-319
20. Lannes B., Bernard V., Bloch B., and Micheletti G. Chronic treatment with dizocilpine maleate increases the number of striatal neurons expressing the d-2 receptor gene. Neuroscience 65 (1995) 431-438
21. Liu Z.H., He Y., Jin W.Q., Chen X.J., Zhang H.P., Shen Q.X., and Chi Z.Q. Binding affinity to and dependence on some opioids in Sf9 insect cells expressing human mu-opioid receptor. Acta Pharmacol. Sin. 24 (2003) 859-863
22. 3H]D-AP5, suggesting down-regulation of the cortical N-methyl-d-aspartate receptors. Neuroscience 30 (1989) 87-94
23. Marshall I., and Weinstock M. A quantitative method for the assessment of physical dependence on narcotic analgesics in mice. Br. J. Pharmacol. 37 (1969) 505P-506P
24. Matthes H.W., Maldonado R., Simonin F., Valverde O., Slowe S., Kitchen I., Befort K., Dierich A., Le Meur M., Dolle P., Tzavara E., Hanoune J., Roques B.P., and Kieffer B.L. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature 383 (1996) 819-823
25. McLemore G.L., Kest B., and Inturrisi C.E. The effects of LY293558, an AMPA receptor antagonist, on acute and chronic morphine dependence. Brain Res. 778 (1997) 120-126
26. Micheletti G., Lannes B., Haby C., Borrelli E., Kempf E., Warter J.M., and Zwiller J. Chronic administration of NMDA antagonists induces D2 receptor synthesis in rat striatum. Mol. Brain Res. 14 (1992) 363-368
27. Miyamoto Y., Bowen W.D., Portoghese P.S., and Takemori A.E. Lack of involvement of delta-1 opioid receptors in the development of physical dependence on morphine in mice. J. Pharmacol. Exp. Ther. 270 (1994) 37-39
28. Narita M., Suzuki T., Misawa M., and Nagase H. Effects of κ opioids on the morphine-induced pharmacological actions. Eur. J. Pharmacol. 183 (1990) 23-28
29. Nehmad R., Nadler H., and Simantov R. Effects of acute and chronic morphine treatment of calmodulin activity of rat brain. Mol. Pharmacol. 22 (1982) 389-394
30. Nestler E.J., Alreja M., and Aghajanian G.K. Molecular and cellular mechanisms of opiate action: studies in the rat locus coeruleus. Brain Res. Bull. 35 (1994) 521-528
31. Oldendorf W.H., Hyman S., Braun L., and Oldendorf S.Z. Blood-brain barrier: penetration of morphine, codeine, heroin, and methadone after carotid injection. Science 178 (1972) 984-986
32. Patel T.R., and McCulloch J. AMPA receptor antagonism attenuates MK-801-induced hypermetabolism in the posterior cingulate cortex. Brain Res. 686 (1995) 254-258
33. Rossi G.C., Pan Y.X., Brown G.P., and Pasternak G.W. Antisense mapping the MOR-1 opioid receptor: evidence for alternative splicing and a novel morphine-6 beta-glucuronide receptor. FEBS Lett. 369 (1995) 192-196
34. Rossi G.C., Brown G.P., Leventhal L., Yang K., and Pasternak G.W. Novel receptor mechanisms for heroin and morphine-6 beta-glucuronide analgesia. Neurosci. Lett. 216 (1996) 1-4
35. Saelens J.K., Granat F.R., and Sawyer W.K. The mouse jumping test-a simple screening method to estimate the physical dependence capacity of analgesics. Arch. Int. Pharmacodyn. Ther. 190 (1971) 213-218
36. Selley D.E., Caob C.-C., Sexton T., Schwegel J.A., Martin T.J., and Childers S.R. Mu opioid receptor-mediated G-protein activation by heroin metabolites: evidence for greater efficacy of 6-monoacetylmorphine compared with morphine. Biochem. Pharmacol. 4 (2001) 447-455
37. Simonin F., Valverde O., Smadja C., Slowe S., Kitchen I., Dierich A., Le M.M., Roques B.P., Maldonado R., and Kieffer B.L. Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50,488H and attenuates morphine withdrawal. EMBO J. 17 (1998) 886-897
38. Smits S.E. Quantitation of physical dependence in mice by naloxone-precipitated jumping after a single dose of morphine. Res. Commun. Chem. Pathol. Pharmacol. 10 (1975) 651-661
39. Suzuki T., Narita M., Takahashi Y., Misawa M., and Nagase H. Effects of nor-binaltorphimine on the development of analgesic tolerance to and physical dependence on morphine. Eur. J. Pharmacol. 213 (1992) 91-97
40. Suzuki T., Ikeda H., Tsuji M., Misawa M., Narita M., and Tseng L.F. Antisense oligodeoxynucleotide to delta opioid receptors attenuates morphine dependence in mice. Life Sci. 61 (1997) PL 165-PL 170
41. Suzuki T., Tsuji M., Mori T., Misawa M., and Nagase H. Involvement of delta 1 and delta 2 opioid receptor subtypes in the development of physical dependence on morphine in mice. Pharmacol. Biochem. Behav. 57 (1997) 293-299
42. Takemori A.E., Loh H.H., and Lee N.M. Suppression by dynorphin A-(l-13) of the expression of opiate withdrawal and tolerance in mice. Eur. J. Pharmacol. 221 (1992) 223-226
43. Trujillo K.A., and Akil H. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 251 (1991) 85-87
44. Vandergriff J., and Rasmussen K. The selective mGlu2/3 receptor agonist LY354740 attenuates morphine-withdrawal-induced activation of locus coeruleus neurons and behavioral signs of morphine withdrawal. Neuropharmacology 38 (1999) 217-222
45. Vekovischeva O.Y., Zamanillo D., Echenko O., Seppala T., Uusi-Oukari M., Honkanen A., Seeburg P.H., Sprengel R., and Korpi E.R. Morphine-induced dependence and sensitization are altered in mice deficient in AMPA-type glutamate receptor-A subunits. J. Neurosci. 21 (2001) 4451-4459
46. Verma A., and Kulkarni S.K. Role of D1/D2 dopamine and N-methyl-d-aspartate (NMDA) receptors in morphine tolerance and dependence in mice. Eur. Neuropsychopharmacol. 5 (1995) 81-87
47. Watkins J., and Collingridge G. Phenylglycine derivatives as antagonists of metabotropic glutamate receptors. Trends Pharmacol. Sci. 15 (1994) 333-342
48. Watson B., Meng F., and Akil H. A chimeric analysis of the opioid receptor domains critical for the binding selectivity of mu opioid ligands. Neurobiol. Dis. 3 (1996) 87-96
49. Wiley J.N., and Downs D.A. Naloxone-precipitated jumping in mice pretreated with acute injections of opioids. Life Sci. 25 (1979) 797-801
50. Zarrindast M.R., Habibi M., Borzabadi S., Fazli-Tabaei S., Hossein Yahyavi S., and Rostamin P. The effects of dopamine receptor agents on naloxone-induced jumping behaviour in morphine-dependent mice. Eur. J. Pharmacol. 45 (2002) 287-293